SOLS vs XRAY · P/E 71, rev $3.89B vs rev $1.78B
Solstice Advanced Materials, Inc (SOLS) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Solstice Advanced Materials, Inc (SOLS) is a specialty chemicals company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported SOLS revenue for 2025-12-31 was $3.89B. Net income was $237.0M. Revenue was up 3.1% from 2024-12-31 to 2025-12-31. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
SOLS currently screens at market cap $13.51B and trailing P/E 71.5. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the SOLS and XRAY stock pages for the full models.
Not investment advice.